Skip to content
ClinCalc Pro
Menu
Retinoid + topical antibiotic

Tretinoin with erythromycin

Brand names: Aknemycin Plus

A fixed-combination topical preparation of the retinoid tretinoin with the macrolide antibiotic erythromycin, used to treat acne vulgaris with mixed comedonal and inflammatory lesions.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

Tretinoin normalises follicular keratinocyte turnover to clear and prevent comedones, while erythromycin reduces Cutibacterium acnes colonisation and the associated inflammatory response; the retinoid helps reduce the risk of antibiotic resistance.

Prescribing in practice

  • The retinoid component makes it contraindicated in pregnancy, and women of child-bearing potential should use effective contraception.
  • Topical antibiotic therapy should be time-limited and is best paired with benzoyl peroxide rather than used alone, to reduce the risk of antimicrobial resistance.
  • Local irritation, dryness, peeling and increased photosensitivity are common, so advise sun protection and avoid application to broken or inflamed skin.

Monitoring

No laboratory monitoring is required; review the acne response and skin tolerance and avoid prolonged courses of the antibiotic component.

Counselling the patient

  • Apply a thin layer across the whole affected area at night and protect the skin from the sun during the day.
  • Mild dryness and irritation usually settle; allow several weeks to see benefit.
  • Avoid in pregnancy or when trying to conceive.

Evidence & guidelines

Fixed combinations of a topical retinoid with a topical antibiotic are recommended by NICE for acne, with antibiotic duration minimised to limit resistance.

Reference: NICE NG198; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.